NDC 0078-1021 – Vijoice

Alpelisib 50 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC0078-1021

Product details

Brand name
Vijoice
Generic name
Alpelisib
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
Tablet
Route
Oral
Marketing category
NDA · NDA215039
Marketed since
April 5, 2022
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Vijoice →

Package NDC codes (2)

Package NDCDescriptionSince
0078-1021-841 BLISTER PACK in 1 CARTON (0078-1021-84) / 28 TABLET in 1 BLISTER PACK (0078-1021-51)Apr 5, 2022
0078-1021-91 sample1 BLISTER PACK in 1 CARTON (0078-1021-91) / 28 TABLET in 1 BLISTER PACK (0078-1021-90)Apr 5, 2022

Other Vijoice products